Earl J. Glusac, MD, a Yale Medicine dermatopatholgist and professor of dermatology and pathology at the Yale University School of Medicine, values the essential role he plays in diagnosing skin cancer and other disorders.
“There is probably no more important moment in the care of a patient with skin disease than when a biopsy is interpreted,” says Dr. Glusac.
Because there are hundreds of skin diseases with overlapping features, dermatologists frequently rely on skin pathologists like Dr. Glusac. “I am grateful to have the trust of my clinical colleagues, and I feel privileged to make a significant contribution toward patient care. I feel this responsibility deeply when it comes to interpreting melanocytic lesions (moles and melanoma),” he says.
Dr. Glusac has served as a member of the dermatopathology test development committee of the American Boards of Pathology and Dermatology, an editorial board member of the Journal of Cutaneous Pathology and the American Journal of Dermatopathology, the program director and president of the American Society of Dermatopathology and an author for the World Health Organization’s Classification of Tumours of the Skin.
His research interests include melanocytic neoplasms with emphasis on benign lesions that mimic melanoma.